Hikma Pharmaceuticals nelle notizie
Farmaci accessibili di alta qualità
Tamtam ha trovato 13 articoli recenti su Hikma Pharmaceuticals.
- Hikma stock heads into the open after a modest gain
- What Does Hikma Pharmaceuticals' (LSE:HIK) Dividend Mean For UK Holders?
- Hikma Pharmaceuticals climbs Friday, outperforms market
- Hikma advances its epinephrine nasal spray with multi-market regulatory filings
- A needle-free epinephrine spray is under review in the US, Europe and UK
- Hikma Pharmaceuticals (LSE:HIK) Stock Fair Value Edges Higher After Bullish Analyst Targets
- ii view: Hikma keeps a healthy pulse with solid first half
- Hikma Pharmaceuticals rallies on improving trends
- Hikma Pharmaceuticals Number of Employees 2026 | Employee Count & Headcount Data
- Rep. Cockley Applauds Hikma Pharmaceuticals Expansion, Investment in Columbus Workforce | Republican News
- Skinny labelling after Hikma v Amarin: active inducement in the US Supreme Court (via Passle)
- Hikma Pharmaceuticals Announces Major Expansion in Ohio, Creating 350 New Jobs and Investing $267 Million
- Justices poised to protect generics manufacturers from liability for decisions of pharmacists about prescribing their products
Articoli raccolti da Tamtam e conservati quando riguardano l'azienda, dal più recente. Ognuno rimanda alla sua fonte.
Vendi ad aziende come Hikma Pharmaceuticals?
Tamtam trova le aziende in linea con il tuo cliente ideale, analizza ogni account e ti dice chi contattare e quando.
Trova aziende simili